Table 2. Observed and relative survival rates (%) in patients with oesophageal squamous cell carcinoma and oesophageal adenocarcinoma in 1961–2008, and cardia adenocarcinoma and gastric non-cardia adenocarcinoma in 1970–2008, and follow-up until 2009 in Sweden.
| Observed survival rate (95% confidence interval) | Relative survival rate (95% confidence interval) | ||||||||
| Cancer | Period of diagnosis | Number of patients (%) | Mean age at diagnosis | 1 year | 3 years | 5 years | 1 year | 3 years | 5 years |
| Esophageal squamous | 1961–1969 | 1414 | 68.9 | 24.8 (22.5–27.0) | 6.6 (5.3–7.9) | 4.3 (3.2–5.3) | 26.1 (23.7–28.4) | 7.5 (6.0–9.0) | 5.0 (3.8–6.3) |
| cell carcinoma | 1970–1979 | 1942 | 69.2 | 27.3 (25.4–29.3) | 8.4 (7.1–9.8) | 6.0 (4.8–7.1) | 28.8 (26.7––30.8) | 9.4 (7.9–10.9) | 7.1 (5.7–8.4) |
| 1980–1989 | 2353 | 69.9 | 31.2 (29.3–33.1) | 10.1 (8.7–11.5) | 7.4 (6.2–8.6) | 32.8 (30.8–34.7) | 11.2 (9.7–12.7) | 8.6 (7.2–10.0) | |
| 1990–1999 | 2252 | 70.0 | 33.5 (31.6–35.5) | 12.5 (11.1–14) | 9.3 (8.0–10.6) | 35.0 (33.0–37.1) | 13.6 (12–15.2) | 10.5 (9.0–11.9) | |
| 2000–2008 | 1655 | 70.1 | 35.3 (33.0–37.7) | 13.4 (11.6–15.1) | 9.3 (7.8–10.9) | 36.7 (34.3–39.1) | 14.3 (12.4–16.1) | 10.3 (8.5–12.0) | |
| Esophageal | 1961–1969 | 215 | 67.4 | 29.8 (23.7–35.9) | 7.0 (3.6–10.4) | 5.6 (2.5–8.6) | 31.1 (24.7–37.5) | 7.8 (4.0–11.6) | 6.6 (3.0–10.2) |
| adenocarcinoma | 1970–1979 | 360 | 69.3 | 27.2 (22.6–31.8) | 6.1 (3.5–8.7) | 3.2 (1.3–5.1) | 28.7 (23.9–33.6) | 6.8 (3.9–9.8) | 3.7 (1.4–5.9) |
| 1980–1989 | 531 | 70.1 | 29.4 (25.5–33.3) | 7.6 (5.1–10.1) | 5.9 (3.7–8.1) | 31.1 (27.0–35.2) | 8.3 (5.6–11) | 6.7 (4.2–9.2) | |
| 1990–1999 | 909 | 70.3 | 35.6 (32.5–38.8) | 16.4 (13.9–18.8) | 10.6 (8.5–12.6) | 37.4 (34.2–40.7) | 18.1 (15.4–20.8) | 12.5 (10.1–14.9) | |
| 2000–2008 | 1707 | 69.6 | 40.1 (37.7–42.4) | 17.1 (15.2–19.0) | 13.1 (11.3–14.8) | 41.8 (39.4–44.2) | 18.4 (16.4–20.4) | 14.6 (12.6–16.6) | |
| Gastric cardia | 1970–1979 | 951 | 68.3 | 27.3 (24.5–30.2) | 8.8 (6.9–10.7) | 4.9 (3.4–6.3) | 28.7 (25.7–31.7) | 9.7 (7.6–11.7) | 5.6 (3.9–7.3) |
| adenocarcinoma | 1980–1989 | 1563 | 69.9 | 36.6 (34.2–39.0) | 12.6 (10.8–14.3) | 8.8 (7.3–10.3) | 38.5 (36.0–41.0) | 13.8 (11.9–15.8) | 10.3 (8.5–12.0) |
| 1990–1999 | 1981 | 69.9 | 37.1 (34.9–39.2) | 13.8 (12.2–15.3) | 9.6 (8.3–10.9) | 38.9 (36.7–41.2) | 15.2 (13.5–16.9) | 11.1 (9.6–12.6) | |
| 2000–2008 | 1743 | 69.2 | 41.0 (38.7–43.3) | 17.5 (15.6–19.3) | 12.4 (10.7–14.1) | 42.7 (40.3–45.1) | 19.1 (17.0–21.1) | 14.3 (12.3–16.3) | |
| Gastric non–cardia | 1970–1979 | 15520 | 70.1 | 35.1 (34.4–35.9) | 16.8 (16.2–17.5) | 12.5 (11.9–13.1) | 37.2 (36.4–38.0) | 19.0 (18.2–19.7) | 15.2 (14.5–15.9) |
| adenocarcinoma | 1980–1989 | 14260 | 72.1 | 43.7 (42.9–44.5) | 22.3 (21.5–23.1) | 16.9 (16.2–17.6) | 46.5 (45.6–47.3) | 25.3 (24.5–26.2) | 20.7 (19.9–21.6) |
| 1990–1999 | 9619 | 72.8 | 42.0 (41.0–43.0) | 21.9 (21.0–22.7) | 16.5 (15.7–17.3) | 44.5 (43.5–45.6) | 24.9 (23.9–25.8) | 20.2 (19.2–21.1) | |
| 2000–2008 | 5876 | 73.1 | 41.4 (40.2–42.7) | 20.4 (19.3–21.5) | 15.7 (14.7–16.8) | 43.8 (42.5–45.1) | 23.0 (21.8–24.2) | 19.0 (17.7–20.2) | |